Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer
The gastrin-releasing peptide receptor (GRPR) is a promising molecular target for imaging and therapy of prostate cancer using bombesin peptides that bind to the receptor with high affinity. Targeted copper theranostics (TCTs) using copper radionuclides, <sup>64</sup>Cu for imaging and &...
Saved in:
Main Authors: | Truc T. Huynh (Author), Ellen M. van Dam (Author), Sreeja Sreekumar (Author), Cedric Mpoy (Author), Benjamin J. Blyth (Author), Fenella Muntz (Author), Matthew J. Harris (Author), Buck E. Rogers (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Efficacy of <sup>177</sup>Lu-Labeled A20FMDV2 Peptides Targeting α<sub>ν</sub>β<sub>6</sub>
by: Truc Thao Huynh, et al.
Published: (2022) -
Diagnosis of Prostate Cancer with a Neurotensin-Bombesin Radioligand Combination-First Preclinical Results
by: Maria Bibika, et al.
Published: (2024) -
Theranostic Potential of the iPSMA-Bombesin Radioligand in Patients with Metastatic Prostate Cancer: A Pilot Study
by: Sofía González-Rueda, et al.
Published: (2024) -
RADIONUCLIDE DIAGNOSTICS OF BONE METASTASES IN PATIENTS WITH PROSTATE CANCER
by: E. Portnyaga, et al.
Published: (2016) -
Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer
by: Tyrillshall S. T. Damiana, et al.
Published: (2021)